We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Inhaled Doxorubicin in Treating Patients With Primary Lung Cancer or Lung Metastases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00004930
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : June 19, 2013
National Cancer Institute (NCI)
Information provided by:
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2004
  Study Completion Date : February 2004